Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 13311-84-7 | Product Number: F0663
Flutamide
Purity: >98.0%(GC)
- 4'-Nitro-3'-(trifluoromethyl)isobutyranilide
- 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | F0663 |
Purity / Analysis Method
|
>98.0%(GC) |
| Molecular Formula / Molecular Weight | C__1__1H__1__1F__3N__2O__3 = 276.22 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| Condition to Avoid | Light Sensitive |
| CAS RN | 13311-84-7 |
| Reaxys Registry Number | 2157663 |
| PubChem Substance ID | 87560202 |
| Merck Index (14) | 4208 |
| MDL Number | MFCD00072009 |
| Appearance | White to Light yellow to Green powder to crystal |
| Purity(GC) | min. 98.0 % |
| Melting point | 110.0 to 114.0 °C |
| Melting Point | 112 °C |
| Solubility in water | Insoluble |
| Solubility (soluble in) | Chloroform, Ether |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H361 : Suspected of damaging fertility or the unborn child. H370 : Causes damage to organs. |
| Precautionary Statements | P260 : Do not breathe dust. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. |
| EC Number | 236-341-9 |
| RTECS# | UG5700000 |
| HS Number | 2924297099 |
References
- Biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'-trifluoromethylisobutyranilide)
- Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
- Mechanism of action and pure antiandrogenic properties of flutamide
- Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist
- Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer
- Flutamide. A review of methods of preparation, physical properties, stability, metabolism and pharmacokinetics and methods for the detection of flutamide
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.